《美国股市》道指升337点或1.1% 苹果升5%
美股上升,纳指创新高,受市场对新刺激经济方案预期所推动。报道指苹果iPhone预计明年上半年增产三成,推升苹果股价,带动美股三大指数向上。道指高开57点後升幅扩大,尾市曾升381点见30,243点。
道琼斯工业平均指数升337.76点或1.1%,收报30,199.31点。
标准普尔500指数升47.13点或1.3%,收报3,694.62点。
纳斯达克指数升155.02点或1.3%,收报12,595.06点。
苹果升5%,为升幅最大道指成分股。迪士尼升2.7%,国际商业机器、高盛、陶氏、卡特彼勒、Nike及旅行家集团各升1.9%至2.4%。Salesforce跌0.5%,为跌幅最大道指成分股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.